The new RAREFIND #MSCA-COFUND PhD Program offers a unique opportunity to dive into cutting-edge #genetherapy and #celltherapy research with top-tier, interdisciplinary training across 22 leading labs at TIGEM and SR-Tiget.
The new RAREFIND #MSCA-COFUND PhD Program offers a unique opportunity to dive into cutting-edge #genetherapy and #celltherapy research with top-tier, interdisciplinary training across 22 leading labs at TIGEM and SR-Tiget.
RAREFIND #MSCA-COFUND #PhD Programme opens its call for applications!
👉Know more and apply now: www.rarefind-cofund.eu
#RAREFINDPhD
RAREFIND #MSCA-COFUND #PhD Programme opens its call for applications!
👉Know more and apply now: www.rarefind-cofund.eu
#RAREFINDPhD
At TIGEM, we stand with patients — especially those with MPS VI (Maroteaux-Lamy syndrome), a rare lysosomal disorder caused by ARSB gene mutations.
At TIGEM, we stand with patients — especially those with MPS VI (Maroteaux-Lamy syndrome), a rare lysosomal disorder caused by ARSB gene mutations.
We have 2 open positions at TIGEM in the PhD program in Systems Medicine.
Deadline: June 9th – don’t miss it!
Apply here: www.semm.it/education/ho...
#PhD #SystemsMedicine #TIGEM #SEMM #PhDOpportunity #BiomedicalResearch #CallForApplications
We have 2 open positions at TIGEM in the PhD program in Systems Medicine.
Deadline: June 9th – don’t miss it!
Apply here: www.semm.it/education/ho...
#PhD #SystemsMedicine #TIGEM #SEMM #PhDOpportunity #BiomedicalResearch #CallForApplications
Read the full story here: www.tigem.it/newsroom/new...
Read the full story here: www.tigem.it/newsroom/new...